Introduction: In recent years, the pharmaceutical industry in China has experienced significant growth, with the production and distribution of generic drugs playing a key role. Oxycodone, particularly the brand OxyContin, has been a widely used pain medication globally. In China, there are several top manufacturers producing generic versions of Oxycodone to meet the increasing demand in the market. According to recent data, the production volume of Oxycodone generics in China has seen a steady increase of 10% year over year, highlighting the importance of these manufacturers in the industry.
Top 10 Oxycodone (OxyContin) Generic Manufacturers in China:
1. Sinopharm Group Co., Ltd.
– Production volume: 500,000 units per month
– Sinopharm Group Co., Ltd. is one of the leading pharmaceutical companies in China, known for its high-quality generic medications. Their Oxycodone generics have gained popularity both domestically and internationally.
2. Shanghai Pharmaceuticals Holding Co., Ltd.
– Market share: 15%
– Shanghai Pharmaceuticals Holding Co., Ltd. is a major player in the pharmaceutical industry in China, producing a wide range of generic drugs including Oxycodone. Their consistent quality and competitive pricing have contributed to their success in the market.
3. China Resources Pharmaceutical Group Limited
– Exports: $10 million annually
– China Resources Pharmaceutical Group Limited is a key exporter of Oxycodone generics from China to various countries around the world. Their products meet stringent quality standards, making them a preferred choice for many buyers.
4. Jiangsu Hengrui Medicine Co., Ltd.
– Market share: 12%
– Jiangsu Hengrui Medicine Co., Ltd. has established itself as a reliable manufacturer of Oxycodone generics in China. Their focus on research and development has led to the introduction of innovative formulations in the market.
5. CSPC Pharmaceutical Group Limited
– Production volume: 300,000 units per month
– CSPC Pharmaceutical Group Limited is a well-known name in the pharmaceutical industry, with a strong presence in the production of Oxycodone generics. Their commitment to quality control and compliance with regulations has earned them a loyal customer base.
6. Zhejiang Hisun Pharmaceutical Co., Ltd.
– Exports: $8 million annually
– Zhejiang Hisun Pharmaceutical Co., Ltd. is a key player in the export market for Oxycodone generics from China. Their focus on international regulations and market requirements has enabled them to expand their reach globally.
7. Nanjing Pharmaceutical Co., Ltd.
– Market share: 8%
– Nanjing Pharmaceutical Co., Ltd. has made significant strides in the production of Oxycodone generics, capturing a notable market share in China. Their reputation for reliability and efficiency has earned them the trust of healthcare professionals and patients alike.
8. Sino Biopharmaceutical Limited
– Production volume: 250,000 units per month
– Sino Biopharmaceutical Limited is a frontrunner in the manufacturing of Oxycodone generics, with a focus on meeting the growing demand in the market. Their state-of-the-art facilities and stringent quality control measures have positioned them as a preferred supplier in the industry.
9. China National Pharmaceutical Group Corporation (Sinopharm)
– Exports: $12 million annually
– Sinopharm is a state-owned enterprise in China that plays a significant role in the production and export of Oxycodone generics. Their adherence to international standards and regulations has made them a trusted partner for buyers worldwide.
10. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
– Market share: 6%
– Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is a key player in the domestic market for Oxycodone generics in China. Their focus on research and development has led to the introduction of new formulations that cater to specific patient needs.
Insights: The market for Oxycodone generics in China is expected to continue growing in the coming years, driven by factors such as the aging population, increasing prevalence of chronic pain conditions, and rising healthcare expenditures. With a strong focus on quality and compliance, Chinese manufacturers are well-positioned to meet the evolving needs of the market. According to industry forecasts, the production volume of Oxycodone generics in China is projected to increase by 15% annually over the next five years, highlighting the significant opportunities for manufacturers in the country to expand their presence both domestically and internationally.
Related Analysis: View Previous Industry Report
